Holen Sie sich die Stockscreener-App
4.35
3.33%
-0.15
Handel nachbörslich:
4.39
0.04
+0.92%
Schlusskurs vom Vortag:
$4.50
Offen:
$4.5
24-Stunden-Volumen:
94,561
Relative Volume:
0.14
Marktkapitalisierung:
$155.94M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-9.19%
1M Leistung:
-19.44%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$4.20
$4.50
1-Wochen-Bereich:
$4.19
$4.80
52-Wochen-Spanne:
$3.85
$26.62
Bioage Labs Inc Stock (BIOA) Company Profile
Firmenname
Bioage Labs Inc
Sektor
Telefon
510-806-1445
Adresse
1445A SOUTH 50TH STREET, RICHMOND
Vergleichen Sie BIOA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BIOA
Bioage Labs Inc
|
4.35 | 155.94M | 0 | 0 | 0 | 0.00 |
|
ZTS
Zoetis Inc
|
165.31 | 74.02B | 9.26B | 2.49B | 2.30B | 5.47 |
|
HLN
Haleon Plc Adr
|
10.15 | 45.90B | 14.26B | 1.55B | 0 | 0.3383 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.08 | 44.64B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.78 | 19.23B | 16.54B | -1.64B | 749.00M | -1.45 |
|
ITCI
Intra Cellular Therapies Inc
|
128.57 | 13.67B | 612.78M | -86.37M | -62.91M | -0.87 |
Bioage Labs Inc Stock (BIOA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-10 | Herabstufung | Morgan Stanley | Overweight → Underweight |
| 2024-12-09 | Herabstufung | Citigroup | Buy → Neutral |
| 2024-12-09 | Herabstufung | Jefferies | Buy → Hold |
| 2024-10-21 | Eingeleitet | Citigroup | Buy |
| 2024-10-21 | Eingeleitet | Jefferies | Buy |
| 2024-10-21 | Eingeleitet | Morgan Stanley | Overweight |
Alle ansehen
Bioage Labs Inc Aktie (BIOA) Neueste Nachrichten
Bragar Eagel & Squire, P.C. Reminds Investors That Class - GlobeNewswire
2025-02-24 | BioAge Labs, Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky for More InformationBIOA | NDAQ:BIOA | Press Release - Stockhouse Publishing
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of BioAge Labs - TradingView
BioAge Labs (BIOA) Abandons Obesity Drug Amid Shareholder Lawsuit – Hagens Berman - GlobeNewswire
Investors in BioAge Labs, Inc. Should Contact Levi & Korsinsky Before March 10, 2025 to Discuss Your RightsBIOA - Stockhouse Publishing
Lost Money on BioAge Labs, Inc.(BIOA)? Join Class Action Suit Seeking Recovery – Contact Levi & Korsinsky - GlobeNewswire
2025-02-24 | Investors who Lost Money on BioAge Labs, Inc.(BIOA) Should Contact Levi & Korsinsky About Pending Class ActionBIOA | NDAQ:BIOA | Press Release - Stockhouse Publishing
2025-02-24 | BioAge Labs, Inc. Class Action: Levi & Korsinsky Reminds BioAge Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 10, 2025BIOA | NDAQ:BIOA | Press Release - Stockhouse Publishing
The Gross Law Firm Notifies Shareholders of BioAge Labs, Inc.(BIOA) of a Class Action Lawsuit and an Upcoming Deadline - PR Newswire
BIOA Deadline: BIOA Investors with Losses in Excess of $100K Have Opportunity to Lead BioAge Labs, Inc. Securities Lawsuit - PR Newswire
Class Action Filed Against BioAge Labs, Inc. (BIOA)March 10, 2025 Deadline to JoinContact Levi & Korsinsky - Stockhouse Publishing
BIOA IMPORTANT DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, - GlobeNewswire
BIOA IMPORTANT DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages BioAge Labs, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – BIOA - GlobeNewswire Inc.
2025-02-23 | BioAge Labs, Inc. Sued for Securities Law ViolationsContact Levi & Korsinsky Before March 10, 2025 to Discuss Your RightsBIOA | NDAQ:BIOA | Press Release - Stockhouse Publishing
BIOA CLASS ACTION DEADLINE: BioAge Labs Investors with - GlobeNewswire
Levi & Korsinsky Notifies Shareholders of BioAge Labs, Inc.(BIOA) of a Class Action Lawsuit and an Upcoming Deadline - Stockhouse Publishing
BioAge Labs, Inc. Investors Reminder: Kessler Topaz Meltzer & Check, LLP Reminds BioAge Labs, Inc. Shareholders of Deadline in Securities Fraud Class Action Lawsuit - PR Newswire
BioAge Labs, Inc. Sued for Securities Law Violations – - GlobeNewswire
2025-02-21 | Levi & Korsinsky Notifies Shareholders of BioAge Labs, Inc. (BIOA) of a Class Action Lawsuit and an Upcoming Deadline | NDAQ:BIOA | Press Release - Stockhouse Publishing
Deadline Alert: BioAge Labs, Inc. (BIOA) Investors Who Lost - GlobeNewswire
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of BioAge Labs, Inc.(BIOA) Shareholders - Morningstar
Class Action Filed Against BioAge Labs, Inc. (BIOA) Seeking Recovery for InvestorsContact Levi & Korsinsky - Stockhouse Publishing
ROSEN, NATIONAL TRIAL LAWYERS, Encourages BioAge Labs, Inc. Investors to Secure Counsel Before ... - The Bakersfield Californian
BioAge Labs to Participate in TD Cowen's 45th Annual Health Care Conference - The Manila Times
BioAge Labs, Inc. (BIOA) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire
Faruqi & Faruqi Reminds BioAge Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 10, 2025BIOA - PR Newswire
2025-02-20 | BioAge Labs, Inc. Class Action: Levi & Korsinsky Reminds BioAge Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 10, 2025BIOA | NDAQ:BIOA | Press Release - Stockhouse Publishing
2025-02-20 | Shareholders of BioAge Labs, Inc. Should Contact Levi & Korsinsky Before March 10, 2025 to Discuss Your RightsBIOA | NDAQ:BIOA | Press Release - Stockhouse Publishing
Shareholders that lost money on BioAge Labs, Inc.(BIOA) should contact The Gross Law Firm about pending Class ActionBIOA - PR Newswire
Lost Money on BioAge Labs, Inc. (BIOA)? Join Class Action Suit Seeking RecoveryContact Levi & Korsinsky - Stockhouse Publishing
BIOA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of BioAge Labs - GlobeNewswire
2025-02-19 | BIOA LAWSUIT ALERT: Levi & Korsinsky Notifies BioAge Labs, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline | NDAQ:BIOA | Press Release - Stockhouse Publishing
2025-02-18 | BioAge Labs, Inc. Sued for Securities Law ViolationsContact Levi & Korsinsky Before March 10, 2025 to Discuss Your RightsBIOA | NDAQ:BIOA | Press Release - Stockhouse Publishing
BIOA STOCK NEWS: Robbins LLP Reminds BioAge Labs, Inc. Investors of the Pending Lead Plaintiff ... - The Bakersfield Californian
BIOA STOCK NEWS: Robbins LLP Reminds BioAge Labs, Inc. - GlobeNewswire
Kirby McInerney LLP Urges Investors in BioAge Labs, Inc. (BIOA) to Inquire About Their Rights in Class Action Lawsuit - Business Wire
BIOA Deadline Approaching on March 10, 2025: Kessler Topaz Meltzer & Check, LLP Reminds BioAge Labs, Inc. (BIOA) Investors of Class Action Lawsuit Deadline | FinancialContent Business Page - Financial Content
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in BioAge Labs, Inc. of Class Action Lawsuit and Upcoming DeadlinesBIOA - PR Newswire
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 10, 2025 in BioAge Lawsuit – BIOA - GlobeNewswire
2025-02-18 | BioAge Labs, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before March 10, 2025 to Discuss Your RightsBIOA | NDAQ:BIOA | Press Release - Stockhouse Publishing
BIOA Investors Have Opportunity to Lead BioAge Labs, Inc. Securities Fraud Lawsuit with the Schall Law Firm - Morningstar
Deadline Alert: Join Class Action Lawsuit Against BIOA by March 10, 2025 – Contact Levi & Korsinsky - The Octant
BioAge Labs (BIOA) Shares Plummet After Discontinuing Trial Just 2 Months After IPO– Hagens Berman - GlobeNewswire
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages BioAge Labs, Inc. Investors to Secure Counsel Before ... - The Bakersfield Californian
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages BioAge Labs, - GlobeNewswire
BioAge Labs Inc (BIOA) gets rating Downgrade from Morgan Stanley - Knox Daily
2025-02-17 | BioAge Labs, Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky Before March 10, 2025 to Discuss Your RightsBIOA | NDAQ:BIOA | Press Release - Stockhouse Publishing
Kessler Topaz Meltzer & Check, LLP Announces Securities Fraud Class Action Lawsuit Filed Against BioAge Labs, Inc. - Financial Content
2025-02-16 | Shareholders that lost money on BioAge Labs, Inc.(BIOA) should contact Levi & Korsinsky about pending Class ActionBIOA | NDAQ:BIOA | Press Release - Stockhouse Publishing
2025-02-16 | Shareholders that Lost Money on BioAge Labs, Inc. (BIOA) Should Contact Levi & Korsinsky About Pending Class ActionBIOA | NDAQ:BIOA | Press Release - Stockhouse Publishing
Finanzdaten der Bioage Labs Inc-Aktie (BIOA)
Es liegen keine Finanzdaten für Bioage Labs Inc (BIOA) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.92%
1.31%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):